Cargando…
Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
Serotonin (5-hydroxytryptamine, 5-HT) as well as noradrenaline (NA) are key modulators of various fundamental brain functions including the control of appetite. While manipulations that alter brain serotoninergic signaling clearly affect body weight, studies implicating 5-HT transporters and NA tran...
Autores principales: | Griebsch, Nora-Isabell, Kern, Johanna, Hansen, Jonas, Rullmann, Michael, Luthardt, Julia, Helfmeyer, Stephanie, Dekorsy, Franziska J., Soeder, Marvin, Hankir, Mohammed K., Zientek, Franziska, Becker, Georg-Alexander, Patt, Marianne, Meyer, Philipp M., Dietrich, Arne, Blüher, Matthias, Ding, Yu-Shin, Hilbert, Anja, Sabri, Osama, Hesse, Swen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688491/ https://www.ncbi.nlm.nih.gov/pubmed/36358364 http://dx.doi.org/10.3390/brainsci12111437 |
Ejemplares similares
-
Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020) -
Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
por: Soeder, J. Marvin, et al.
Publicado: (2021) -
HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
por: Schinke, Christian, et al.
Publicado: (2022) -
Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022) -
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)